NOVT Stock News

BEDFORD, Mass. — Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quar…

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quart

If you own shares in Novanta Inc. (NASDAQ:NOVT) then it's worth thinking about how it contributes to the volatility of...

Novanta Inc (NASDAQ:NOVT) CEO Matthijs Glastra sold 8,000 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $89.53, for a total value of $716,2

The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use...

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Gla

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towar

In 2016 Matthijs Glastra was appointed CEO of Novanta Inc. (NASDAQ:NOVT). This report will, first, examine the CEO...

Q3 2019 Novanta Inc Earnings Call

We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...

Novanta (NOVT) delivered earnings and revenue surprises of 1.92% and -0.70%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Novanta (NOVT) delivered earnings and revenue surprises of 1.92% and -0.70%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported f

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Novanta (NOVT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.